Welcome to our dedicated page for HERITAGE CANNABIS HLDGS news (Ticker: HERTF), a resource for investors and traders seeking the latest updates and insights on HERITAGE CANNABIS HLDGS stock.
Heritage Cannabis Holdings Corp. (HERTF) provides investors and industry observers with essential updates through this centralized news hub. Track official press releases, strategic developments, and operational updates from the cannabis-focused asset management company.
Discover timely information about corporate restructuring initiatives under the Companies' Creditors Arrangement Act (CCAA), portfolio optimization efforts, and regulatory compliance milestones. This resource aggregates earnings announcements, asset transaction details, and management commentary to support informed market analysis.
Key updates include production capacity changes, partnership developments, and financial restructuring progress. The curated collection serves as a reliable reference for understanding HERTF's position within evolving cannabis markets and its approach to operational resilience.
Bookmark this page for streamlined access to verified corporate communications. Check regularly for new filings and strategic updates directly from Heritage Cannabis Holdings and authorized news sources.
Heritage Cannabis Holdings Corp. (OTCQX: HERTF) has secured a purchase order from a Brazilian pharmaceutical company for the wholesale distribution of CBD products, which are now approved by the Brazil Health Authority (ANVISA). This marks a significant advance as these products are among the first to receive such approval. Following prior successful testing shipments, the company is positioned for its first full shipment. CEO David Schwede emphasized the importance of expanding globally and mentioned ongoing efforts to establish a long-term supply agreement that may include THC products once fully legalized in Brazil.
Heritage Cannabis Holdings Corp. reported its financial results for the quarter ended January 31, 2023, revealing gross revenue of
Heritage Cannabis Holdings Corp. (CSE: CANN, OTCQX: HERTF) has received approval from Brazil's Health Authority (ANVISA) to import its first formulated CBD product into Brazil. This achievement follows Health Canada granting Heritage the first license to export cannabis products from Canada to Brazil in 2021. With a significant population and a promising market outlook, Brazil presents numerous opportunities for Heritage to expand. The company is also working on two additional products pending final approval. CEO David Schwede emphasizes the strategic importance of this market entry for Heritage's product reach.
